DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

Historical Holders from Q4 2018 to Q3 2025

Symbol
DMAC on Nasdaq
Type / Class
Equity / Voting Common Shares, no par value
Shares outstanding
51,654,406
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
12,754,591
Holdings value
$82,807,935
% of all portfolios
0%
Number of holders
77
Number of buys
55
Number of sells
-13
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TomEnterprise AB 16.28% $32,695,950 8,383,577 TomEnterprise AB 23 Jul 2025
TRILL AB 15.02% +14% $46,586,790 +$6,000,000 7,764,465 +15% Trill AB 14 Aug 2025
JACINTO RICHARD II 9.6% $34,067,114 4,958,823 Richard Jacinto II 30 Sep 2025
COOPERMAN LEON G 6.3% +5% $22,471,432 +$1,096,446 3,269,761 +5.1% Cooperman Leon G. 30 Sep 2025

Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 12,754,591 $82,807,935 +$25,371,563 $6.87 77
2025 Q2 8,764,697 $34,183,334 +$4,951,594 $3.9 58
2025 Q1 7,514,092 $28,477,666 +$2,854,596 $3.79 57
2024 Q4 6,729,012 $36,539,618 +$6,248,431 $5.43 45
2024 Q3 5,580,411 $23,326,555 +$2,250,136 $4.19 40
2024 Q2 5,062,392 $14,934,296 +$1,369,212 $2.95 32
2024 Q1 4,598,019 $12,730,274 +$2,073,072 $2.77 31
2023 Q4 3,840,738 $10,907,609 -$629,214 $2.84 37
2023 Q3 4,250,465 $10,966,479 +$1,920,978 $2.58 35
2023 Q2 3,490,534 $15,080,277 +$4,150,477 $4.32 30
2023 Q1 2,565,385 $3,924,875 +$61,558 $1.53 22
2022 Q4 2,524,139 $3,989,530 -$6,541 $1.58 27
2022 Q3 2,527,104 $3,132,035 -$2,355,232 $1.24 23
2022 Q2 3,668,922 $7,411,731 -$802,498 $2.02 24
2022 Q1 4,006,054 $10,017,522 -$427,839 $2.5 28
2021 Q4 3,993,298 $14,891,858 +$4,430,787 $3.73 34
2021 Q3 2,804,345 $11,247,922 -$4,241,878 $4.01 31
2021 Q2 3,783,974 $16,902,446 -$48,644,584 $4.45 38
2021 Q1 5,694,347 $88,119,211 +$33,217,401 $9.15 38
2020 Q4 5,983,974 $60,607,941 +$30,865 $10.14 34
2020 Q3 6,707,026 $28,383,192 +$15,491,837 $4.24 30
2020 Q2 3,034,327 $21,027,519 +$1,227,002 $6.93 20
2020 Q1 2,928,881 $8,241,240 +$5,983,161 $2.8 18
2019 Q4 806,746 $3,914,130 -$398,177 $4.85 13
2019 Q3 956,852 $1,976,000 -$928,156 $2.07 14
2019 Q2 1,283,324 $6,365,000 +$1,445,583 $4.96 14
2019 Q1 1,013,152 $4,601,000 +$283,018 $4.54 10
2018 Q4 1,032,562 $3,003,000 +$3,003,000 $2.91 7